These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 7611797)

  • 1. Exogenous nonphysiologic vs physiologic lipids. Divergent mechanisms for correction of permeability barrier dysfunction.
    Mao-Qiang M; Brown BE; Wu-Pong S; Feingold KR; Elias PM
    Arch Dermatol; 1995 Jul; 131(7):809-16. PubMed ID: 7611797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exogenous lipids influence permeability barrier recovery in acetone-treated murine skin.
    Man MQ; Feingold KR; Elias PM
    Arch Dermatol; 1993 Jun; 129(6):728-38. PubMed ID: 8507075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coordinate assembly of lipids and enzyme proteins into epidermal lamellar bodies.
    Rassner U; Feingold KR; Crumrine DA; Elias PM
    Tissue Cell; 1999 Oct; 31(5):489-98. PubMed ID: 10612259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimal ratios of topical stratum corneum lipids improve barrier recovery in chronologically aged skin.
    Zettersten EM; Ghadially R; Feingold KR; Crumrine D; Elias PM
    J Am Acad Dermatol; 1997 Sep; 37(3 Pt 1):403-8. PubMed ID: 9308554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The aged epidermal permeability barrier. Structural, functional, and lipid biochemical abnormalities in humans and a senescent murine model.
    Ghadially R; Brown BE; Sequeira-Martin SM; Feingold KR; Elias PM
    J Clin Invest; 1995 May; 95(5):2281-90. PubMed ID: 7738193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fatty acids are required for epidermal permeability barrier function.
    Mao-Qiang M; Elias PM; Feingold KR
    J Clin Invest; 1993 Aug; 92(2):791-8. PubMed ID: 8102380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short-term glucocorticoid treatment compromises both permeability barrier homeostasis and stratum corneum integrity: inhibition of epidermal lipid synthesis accounts for functional abnormalities.
    Kao JS; Fluhr JW; Man MQ; Fowler AJ; Hachem JP; Crumrine D; Ahn SK; Brown BE; Elias PM; Feingold KR
    J Invest Dermatol; 2003 Mar; 120(3):456-64. PubMed ID: 12603860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural and biochemical basis for the UVB-induced alterations in epidermal barrier function.
    Holleran WM; Uchida Y; Halkier-Sorensen L; Haratake A; Hara M; Epstein JH; Elias PM
    Photodermatol Photoimmunol Photomed; 1997 Aug; 13(4):117-28. PubMed ID: 9453079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimization of physiological lipid mixtures for barrier repair.
    Man MQ M; Feingold KR; Thornfeldt CR; Elias PM
    J Invest Dermatol; 1996 May; 106(5):1096-101. PubMed ID: 8618046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topical calcineurin inhibitors compromise stratum corneum integrity, epidermal permeability and antimicrobial barrier function.
    Kim M; Jung M; Hong SP; Jeon H; Kim MJ; Cho MY; Lee SH; Man MQ; Elias PM; Choi EH
    Exp Dermatol; 2010 Jun; 19(6):501-10. PubMed ID: 19703225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural basis for the barrier abnormality following inhibition of HMG CoA reductase in murine epidermis.
    Menon GK; Feingold KR; Mao-Qiang M; Schaude M; Elias PM
    J Invest Dermatol; 1992 Feb; 98(2):209-19. PubMed ID: 1732385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ceramides are transported through the Golgi apparatus in human keratinocytes in vitro.
    Madison KC; Howard EJ
    J Invest Dermatol; 1996 May; 106(5):1030-5. PubMed ID: 8618034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Barrier function regulates epidermal lipid and DNA synthesis.
    Proksch E; Holleran WM; Menon GK; Elias PM; Feingold KR
    Br J Dermatol; 1993 May; 128(5):473-82. PubMed ID: 8504036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Omega-hydroxyceramides are required for corneocyte lipid envelope (CLE) formation and normal epidermal permeability barrier function.
    Behne M; Uchida Y; Seki T; de Montellano PO; Elias PM; Holleran WM
    J Invest Dermatol; 2000 Jan; 114(1):185-92. PubMed ID: 10620136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sphingolipids are required for mammalian epidermal barrier function. Inhibition of sphingolipid synthesis delays barrier recovery after acute perturbation.
    Holleran WM; Man MQ; Gao WN; Menon GK; Elias PM; Feingold KR
    J Clin Invest; 1991 Oct; 88(4):1338-45. PubMed ID: 1918384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ceramides and skin function.
    Coderch L; López O; de la Maza A; Parra JL
    Am J Clin Dermatol; 2003; 4(2):107-29. PubMed ID: 12553851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thematic review series: skin lipids. The role of epidermal lipids in cutaneous permeability barrier homeostasis.
    Feingold KR
    J Lipid Res; 2007 Dec; 48(12):2531-46. PubMed ID: 17872588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic approaches to enhance transdermal drug delivery. 1. Effect of lipid synthesis inhibitors.
    Tsai JC; Guy RH; Thornfeldt CR; Gao WN; Feingold KR; Elias PM
    J Pharm Sci; 1996 Jun; 85(6):643-8. PubMed ID: 8773963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Regulation of the epidermal permeability barrier by lipids and hyperproliferation].
    Proksch E
    Hautarzt; 1992 Jun; 43(6):331-8. PubMed ID: 1628964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Localization of calcium in murine epidermis following disruption and repair of the permeability barrier.
    Menon GK; Elias PM; Lee SH; Feingold KR
    Cell Tissue Res; 1992 Dec; 270(3):503-12. PubMed ID: 1486603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.